Financials
Income statement
Fiscal date | Jan 2025 | Oct 2024 | Jul 2024 | Apr 2024 |
---|---|---|---|---|
Total reported revenue | 135.0M | 72.0M | 59.7M | 60.8M |
Cost of revenue | 49.1M | 26.5M | 22.4M | 20.8M |
Gross profit | 85.9M | 45.5M | 37.3M | 40.0M |
Operating expense | ||||
Research & development | 36.3M | 31.7M | 30.4M | 26.9M |
Selling general and admin | 23.5M | 22.2M | 21.3M | 20.2M |
Other operating expenses | — | — | — | — |
Operating income | 26.2M | -8.4M | -14.5M | -7.1M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | 3.9M | 4.5M | 5.5M | 4.4M |
Pretax income | 30.1M | -3.9M | -8.9M | -2.7M |
Tax provision | 752K | 292K | 622K | 7.8M |
Net income | 29.4M | -4.2M | -9.5M | -10.5M |
Basic EPS | 0.2 | 0.0 | -0.1 | -0.1 |
Diluted EPS | 0.2 | 0.0 | -0.1 | -0.1 |
Basic average shares | 168.2M | 166.5M | 165.1M | 163.7M |
Diluted average shares | 182.5M | 166.5M | 165.1M | 163.7M |
EBITDA | 31.3M | -3.4M | -10.2M | -2.7M |
Net income from continuing op. | 29.4M | -4.2M | -9.5M | -10.5M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |